XPC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 3.658000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
4.561200E-01
Normal-vs-Stage2
3.528600E-01
Normal-vs-Stage3
8.440400E-02
Normal-vs-Stage4
5.520600E-01
Stage1-vs-Stage2
1.417370E-01
Stage1-vs-Stage3
6.679700E-02
Stage1-vs-Stage4
8.511400E-01
Stage2-vs-Stage3
7.093800E-02
Stage2-vs-Stage4
1.299360E-01
Stage3-vs-Stage4
2.446400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
3.765600E-01
Normal-vs-AfricanAmerican
1.455620E-01
Normal-vs-Asian
2.494200E-02
Caucasian-vs-AfricanAmerican
7.912800E-01
Caucasian-vs-Asian
4.073600E-02
AfricanAmerican-vs-Asian
2.368600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
3.484000E-01
Normal-vs-Female
3.864800E-01
Male-vs-Female
3.705400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
9.082600E-01
Normal-vs-Age(41-60Yrs)
4.264400E-01
Normal-vs-Age(61-80Yrs)
2.040200E-02
Normal-vs-Age(81-100Yrs)
3.170600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.166200E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.617700E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.446500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.287700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.307240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.737000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
2.946000E-01
Normal-vs-Daily Drinker
3.311800E-01
Normal-vs-Weekly Drinker
1.505380E-01
Normal-vs-Occasional Drinker
1.116440E-01
Normal-vs-Social Drinker
4.713000E-01
Non Drinker-vs-Daily Drinker
5.226000E-01
Non Drinker-vs-Weekly Drinker
2.729200E-01
Non Drinker-vs-Occasional Drinker
2.039600E-01
Non Drinker-vs-Social Drinker
2.681500E-02
Daily Drinker-vs-Weekly Drinker
5.617800E-01
Daily Drinker-vs-Occasional Drinker
4.885800E-01
Daily Drinker-vs-Social Drinker
1.081160E-01
Weekly Drinker-vs-Occasional Drinker
9.709400E-01
Weekly Drinker-vs-Social Drinker
5.041800E-01
Occasional Drinker-vs-Social Drinker
4.861800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
6.667000E-01
Normal-vs-Grade 2
8.610000E-01
Normal-vs-Grade 3
8.196200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.500400E-01
Grade 1-vs-Grade 3
6.530200E-01
Grade 1-vs-Grade 4
6.667000E-01
Grade 2-vs-Grade 3
3.493200E-01
Grade 2-vs-Grade 4
8.610000E-01
Grade 3-vs-Grade 4
8.196200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
3.570300E-02
Normal-vs-NonDiabetic
3.481400E-01
Diabetic-vs-NonDiabetic
9.108600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
1.118950E-01
Normal-vs-NoPancreatitis
3.542000E-01
Pancreatitis-vs-NoPancreatitis
9.401600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
6.677600E-02
Normal-vs-N1
3.552600E-01
N0-vs-N1
4.957400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
3.664600E-01
Normal-vs-TP53-NonMutant
2.800800E-01
TP53-Mutant-vs-TP53-NonMutant
9.577700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap